Wuhan EasyDiagnosis Biomedicine Co., Ltd. as an IVD reagents, devices and solutions provider with a deep focus on healthcare, EasyDiagnosis was founded in 2008 and went public in Shenzhen Stock Exchange in 2018. EasyDiagnosis strives to develop and share medical technologies in 5 categories: Molecular Diagnosis, Chemiluminescence, Immuno-chromatography, Blood Gas and COVID-19 solution.